These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31737574)

  • 1. Sertraline Delivered in Phosphatidylserine Liposomes Is Effective in an Experimental Model of Visceral Leishmaniasis.
    Romanelli MM; da Costa-Silva TA; Cunha-Junior E; Dias Ferreira D; Guerra JM; Galisteo AJ; Pinto EG; Barbosa LRS; Torres-Santos EC; Tempone AG
    Front Cell Infect Microbiol; 2019; 9():353. PubMed ID: 31737574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoliposomal Buparvaquone Immunomodulates Leishmania infantum-Infected Macrophages and Is Highly Effective in a Murine Model.
    da Costa-Silva TA; Galisteo AJ; Lindoso JA; Barbosa LR; Tempone AG
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting intracellular Leishmania (L.) infantum with nitazoxanide entrapped into phosphatidylserine-nanoliposomes: An experimental study.
    Pinto EG; Barbosa LRS; Mortara RA; Tempone AG
    Chem Biol Interact; 2020 Dec; 332():109296. PubMed ID: 33096056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice.
    Roychoudhury J; Sinha R; Ali N
    PLoS One; 2011 Mar; 6(3):e17376. PubMed ID: 21423750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi.
    Reimão JQ; Colombo FA; Pereira-Chioccola VL; Tempone AG
    Exp Parasitol; 2012 Mar; 130(3):195-9. PubMed ID: 22281156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.
    Vishwakarma P; Parmar N; Yadav PK; Chandrakar P; Kar S
    J Mol Med (Berl); 2016 Jun; 94(6):695-710. PubMed ID: 26830627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis.
    Want MY; Islammudin M; Chouhan G; Ozbak HA; Hemeg HA; Chattopadhyay AP; Afrin F
    Int J Nanomedicine; 2017; 12():2189-2204. PubMed ID: 28356736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani.
    Sinha R; Roychoudhury J; Palit P; Ali N
    Antimicrob Agents Chemother; 2015 Jan; 59(1):344-55. PubMed ID: 25367907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis.
    Everlien H; Hockertz S
    Arzneimittelforschung; 1999 Nov; 49(11):954-61. PubMed ID: 10604050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic of meglumine antimoniate encapsulated in phosphatidylserine-liposomes in mice model: A candidate formulation for visceral leishmaniasis.
    Borborema SET; Osso Junior JA; Tempone AG; de Andrade Junior HF; do Nascimento N
    Biomed Pharmacother; 2018 Jul; 103():1609-1616. PubMed ID: 29864949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral therapy with sertraline, a selective serotonin reuptake inhibitor, shows activity against Leishmania donovani.
    Palit P; Ali N
    J Antimicrob Chemother; 2008 May; 61(5):1120-4. PubMed ID: 18272513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal resiquimod for the treatment of Leishmania donovani infection.
    Peine KJ; Gupta G; Brackman DJ; Papenfuss TL; Ainslie KM; Satoskar AR; Bachelder EM
    J Antimicrob Chemother; 2014 Jan; 69(1):168-75. PubMed ID: 23956375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemisynthetic trifluralin analogues incorporated in liposomes for the treatment of leishmanial infections.
    Carvalheiro M; Esteves MA; Santos-Mateus D; Lopes RM; Rodrigues MA; Eleutério CV; Scoulica E; Santos-Gomes G; Cruz ME
    Eur J Pharm Biopharm; 2015 Jun; 93():346-52. PubMed ID: 25936854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological inhibition of p110δ subunit of PI3K confers protection against experimental leishmaniasis.
    Khadem F; Jia P; Mou Z; Feiz Barazandeh A; Liu D; Keynan Y; Uzonna JE
    J Antimicrob Chemother; 2017 Feb; 72(2):467-477. PubMed ID: 27999013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Leishmania (L.) chagasi amastigotes through macrophage scavenger receptors: the use of drugs entrapped in liposomes containing phosphatidylserine.
    Tempone AG; Perez D; Rath S; Vilarinho AL; Mortara RA; de Andrade HF
    J Antimicrob Chemother; 2004 Jul; 54(1):60-8. PubMed ID: 15163652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete cure of experimental visceral leishmaniasis with amphotericin B in stearylamine-bearing cationic liposomes involves down-regulation of IL-10 and favorable T cell responses.
    Banerjee A; De M; Ali N
    J Immunol; 2008 Jul; 181(2):1386-98. PubMed ID: 18606693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed formulation of conventional and pegylated liposomes as a novel drug delivery strategy for improved treatment of visceral leishmaniasis.
    Azevedo EG; Ribeiro RR; da Silva SM; Ferreira CS; de Souza LE; Ferreira AA; de Oliveira E Castro RA; Demicheli C; Rezende SA; Frézard F
    Expert Opin Drug Deliv; 2014 Oct; 11(10):1551-60. PubMed ID: 24962630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis.
    Islamuddin M; Chouhan G; Want MY; Ozbak HA; Hemeg HA; Afrin F
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005011. PubMed ID: 27776125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of visceral leishmaniasis with sterically stabilized liposomes containing camptothecin.
    Proulx ME; Désormeaux A; Marquis JF; Olivier M; Bergeron MG
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2623-7. PubMed ID: 11502539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromone linked nitrone derivative induces the expression of iNOS2 and Th1 cytokines but reduces the Th2 response in experimental visceral leishmaniasis.
    Mallick S; Halder S; Dutta A; Dey S; Paul K; Maiti S; Bandyopadhyay C; Saha B; Pal C
    Int Immunopharmacol; 2013 Apr; 15(4):772-9. PubMed ID: 23499679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.